Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol on Postoperative Delirium in Elderly Patients
NCT06180876Completed
- Start
- Jul 2022
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in postoperative delirium (POD) (2 arms). Primary endpoint: Incidence of delirium by 3 days after surgery. Started Jul 2022; status: completed.
02
Drugs
remimazolam
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT06180876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06180876.